OC
OGN icon

Oppenheimer & Co’s Organon & Co OGN Stock Holding History

Oppenheimer & Co’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Sell
12,039
-1,209
-9% -$14.5K ﹤0.01% 1682
2026
Q1 		$79.4K Sell
13,248
-376
-3% -$2.83K ﹤0.01% 1652
2025
Q4 		$97.7K Sell
13,624
-8,695
-39% -$68.7K ﹤0.01% 1495
2025
Q3 		$238K Sell
22,319
-836
-4% -$8.2K ﹤0.01% 1478
2025
Q2 		$224K Sell
23,155
-31,010
-57% -$320K ﹤0.01% 1460
2025
Q1 		$807K Buy
54,165
+21,887
+68% +$337K 0.01% 894
2024
Q4 		$482K Buy
32,278
+13,379
+71% +$218K 0.01% 1074
2024
Q3 		$362K Sell
18,899
-8,525
-31% -$177K 0.01% 1157
2024
Q2 		$568K Sell
27,424
-14,664
-35% -$291K 0.01% 967
2024
Q1 		$791K Buy
42,088
+2,186
+5% +$37.5K 0.01% 829
2023
Q4 		$575K Sell
39,902
-24,769
-38% -$337K 0.01% 928
2023
Q3 		$1.12M Sell
64,671
-2,118
-3% -$44.2K 0.02% 636
2023
Q2 		$1.39M Sell
66,789
-51,155
-43% -$1.11M 0.03% 584
2023
Q1 		$2.77M Buy
117,944
+24,994
+27% +$671K 0.06% 365
2022
Q4 		$2.6M Sell
92,950
-8,832
-9% -$226K 0.06% 370
2022
Q3 		$2.38M Sell
101,782
-13,243
-12% -$400K 0.06% 379
2022
Q2 		$3.88M Sell
115,025
-2,860
-2% -$100K 0.08% 279
2022
Q1 		$4.12M Buy
117,885
+36,205
+44% +$1.24M 0.07% 315
2021
Q4 		$2.49M Sell
81,680
-3,511
-4% -$114K 0.04% 446
2021
Q3 		$2.79M Buy
85,191
+8,738
+11% +$280K 0.05% 400
2021
Q2 		$2.31M Buy
+76,453
New +$2.52M 0.04% 471

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Oppenheimer & Co's OGN Position: Q2 2026 in Review

Oppenheimer & Co reduced its Organon & Co (OGN) stake by 9.1% in Q2 2026, selling an estimated $14.5K and leaving 12,039 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

Oppenheimer & Co first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.12M in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Oppenheimer & Co held 12,039 shares of Organon & Co worth $163K as of Q2 2026.
  • Oppenheimer & Co sold 1,209 Organon & Co shares in Q2 2026, an estimated $14.5K.
  • Organon & Co made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1682 holding.
  • Oppenheimer & Co first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Oppenheimer & Co's Organon & Co position peaked at $4.12M in Q1 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.